4-Benzylpiperidine(CAS: 31252-42-3)

4-Benzylpiperidine (CAS: 31252-42-3) falls under the regulatory guidelines of the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) and the European Chemicals Agency (ECHA) under REACH regulations. In the USA, it is classified by the Environmental Protection Agency (EPA) and regulated by the Food and Drug Administration (FDA) for pharmaceutical applications. It is important to ensure compliance with local and national regulations for handling, storage, and disposal.

Yes, there are several alternatives to 4-Benzylpiperidine (CAS: 31252-42-3) in synthesis, including 4-Methylpiperidine and 4-Phenylpiperidine. These compounds can offer similar functional groups for substitution or can provide different properties depending on the desired application. The choice of alternative often depends on the desired chemical properties and the specific requirements of the synthetic route.

The market for 4-Benzylpiperidine (CAS: 31252-42-3) is primarily driven by its use in pharmaceutical research and development. Recent trends show an increasing interest in developing new drugs for pain management and psychiatric disorders, which are expected to drive demand. Research is also focusing on the synthesis of novel analogs and isomers to explore their potential therapeutic benefits.

Waste containing 4-Benzylpiperidine (CAS: 31252-42-3) should be collected in appropriate containers and stored in a well-ventilated area away from ignition sources. Proper incineration or professional waste disposal services should be utilized to handle this waste. Environmental protection measures should include neutralizing the waste to reduce its toxicity before disposal, and following local and national waste management regulations to ensure safe disposal.